Schizophrenia

医学 抗精神病药 指南 精神分裂症(面向对象编程) 社会心理的 精神科 需要治疗的数量 生活质量(医疗保健) 重症监护医学 安慰剂 替代医学 护理部 病理
作者
Alkomiet Hasan,Peter Falkai,Isabell Lehmann,Wolfgang Gäebel
出处
期刊:Deutsches Arzteblatt International [Deutscher Ärzte-Verlag]
被引量:18
标识
DOI:10.3238/arztebl.2020.0412
摘要

The lifetime prevalence of schizophrenia is 1%. Schizophrenia is among the most severe mental illnesses and gives rise to the highest treatment costs per patient of any disease. It is characterized by frequent relapses, marked impairment of quality of life, and reduced social and work participation.The group entrusted with the creation of the German clinical practice guideline was chosen to be representative and pluralistic in its composition. It carried out a systematic review of the relevant literature up to March 2018 and identified a total of 13 389 publications, five source guidelines, three other relevant German clinical practice guidelines, and four reference guidelines.As the available antipsychotic drugs do not differ to any great extent in efficacy, it is recommended that acute antipsychotic drug therapy should be sideeffect- driven, with a number needed to treat (NNT) of 5 to 8. The choice of treatment should take motor, metabolic, sexual, cardiac, and hematopoietic considerations into account. Ongoing antipsychotic treatment is recommended to prevent relapses (NNT: 3) and should be re-evaluated on a regular basis in every case. It is also recommended, with recommendation grades ranging from strong to intermediate, that disorder- and manifestation-driven forms of psychotherapy and psychosocial therapy, such as cognitive behavioral therapy for positive or negative manifestations (effect sizes ranging from d = 0.372 to d = 0.437) or psycho-education to prevent relapses (NNT: 9), should be used in combination with antipsychotic drug treatment. Further aspects include rehabilitation, the management of special treatment situations, care coordination, and quality management. A large body of evidence is available to provide a basis for guideline recommendations, particularly in the areas of pharmacotherapy and cognitive behavioral therapy.The evidence-based diagnosis and treatment of persons with schizophrenia should be carried out in a multiprofessional process, with close involvement of the affected persons and the people closest to them.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
海山了发布了新的文献求助10
2秒前
思源应助guoke采纳,获得20
3秒前
Qing完成签到 ,获得积分10
3秒前
Nene发布了新的文献求助30
3秒前
五羟色胺完成签到,获得积分10
3秒前
3秒前
3秒前
bbj发布了新的文献求助10
4秒前
Paperharvester完成签到,获得积分10
4秒前
tiptip应助feather采纳,获得10
4秒前
5秒前
杨广钰完成签到 ,获得积分20
5秒前
淡然的迎蕾完成签到,获得积分20
5秒前
momo完成签到,获得积分10
6秒前
小蘑菇应助俏皮小土豆采纳,获得10
7秒前
8秒前
8秒前
sanqian911发布了新的文献求助10
8秒前
fiiish发布了新的文献求助10
9秒前
10秒前
夜行者完成签到,获得积分10
11秒前
zhangnana完成签到,获得积分20
11秒前
12秒前
trump发布了新的文献求助10
12秒前
12秒前
FlightAttendant完成签到 ,获得积分10
13秒前
Jasper应助悦耳的闭月采纳,获得10
13秒前
小太阳发布了新的文献求助10
13秒前
14秒前
14秒前
bkagyin应助似我采纳,获得10
14秒前
科研通AI6.3应助似我采纳,获得10
14秒前
科研通AI6.3应助似我采纳,获得10
14秒前
英姑应助似我采纳,获得10
14秒前
鱼YUYU完成签到,获得积分10
16秒前
杜妤涵完成签到,获得积分10
16秒前
17秒前
17秒前
wen完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Various Faces of Animal Metaphor in English and Polish 800
Fundamentals of Strain Psychology 800
The SAGE Dictionary of Qualitative Inquiry 610
Signals, Systems, and Signal Processing 610
An Introduction to Medicinal Chemistry 第六版习题答案 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6343841
求助须知:如何正确求助?哪些是违规求助? 8158873
关于积分的说明 17154268
捐赠科研通 5400123
什么是DOI,文献DOI怎么找? 2860279
邀请新用户注册赠送积分活动 1838285
关于科研通互助平台的介绍 1687864